Skip to main content
Caplight Logo









Cellino

Cellino

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://cellinobio.com/

Last Round

Grant

Sep 10, 2024

Est. Valuation

$150M

Total Funding Raised

$125M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cellino is a biotechnology company that develops an AI-guided laser editing platform to facilitate the scalable production of personalized autologous cell therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Precision Medicine, Smart Manufacturing, Medical AI

Business Model

B2B

Customer Profile

Hardware + Subscription, Services & Consulting, Government Contracts

AI Layer

Infrastructure

Keywords

autonomous biomanufacturing platformautologous cell therapy manufacturinginduced pluripotent stem cell (iPSC) productionAI-driven cell therapy manufacturingscalable iPSC manufacturingcell therapy manufacturing partnerlaser-based cell editinglabel-free imaging for cell quality controlFDA Advanced Manufacturing Technology (AMT) designated platformregenerative medicine manufacturing platformclosed-loop bioprocessing automationdigital simulation for bioprocessing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellino Comparables

Compare Cellino with similar companies based on industry and business-model similarity.

Cellino comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Multiply Labs
84%
Ori Biotech
78%
Cellular Origins
78%

Cellino Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 10, 2024
Series AJan 25, 2022
SeedFeb 1, 2021
SeedAug 9, 2019

Key People

Founding team and executive leadership

Marinna Madrid

Co-Founder, Chief Product & Regulatory Officer

Founding Team

Nabiha Saklayen

CEO And Co-Founder

Founding Team

Abhijit Kulkarni

Chief Operating Officer

Executive Team

Ed Tekeian

Chief Operating Officer, Senior Vice President of Engineering

Executive Team

Cellino Investors

Notable investors and investment history

Cellino investors
InvestorRounds
The EngineSeries A, Seed
Engine VenturesSeries A, Seed
Khosla VenturesSeries A, Seed
Humboldt FundSeed, Series A
Engine VenturesSeed
ARPA-HGrant
8VCSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 24, 2026

    Named to Fast Company's Most Innovative Companies list for 2026.

  • Apr 15, 2025

    Developing first Nebula-powered iPSC therapy for cardiovascular disease with Karis Bio.

Cellino Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cellino Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cellino's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range108
Year Founded2017
Last FundingSep 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?